Literature DB >> 33687482

Aneurysm Rupture 5.5 Years after Woven EndoBridge device (WEB) Implantation.

Elmar Spuentrup1,2, Carolin Spüntrup3, Fortesa Bytyqi4,5, Christoph Kabbasch6, Jan Walter4,5.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 33687482     DOI: 10.1007/s00062-021-01004-6

Source DB:  PubMed          Journal:  Clin Neuroradiol        ISSN: 1869-1439            Impact factor:   3.649


× No keyword cloud information.
  4 in total

1.  Predicting Factors of Angiographic Aneurysm Occlusion after Treatment with the Woven EndoBridge Device: A Single-Center Experience with Midterm Follow-Up.

Authors:  F Cagnazzo; R Ahmed; R Zannoni; C Dargazanli; P-H Lefevre; G Gascou; I Derraz; C Riquelme; A Bonafe; V Costalat
Journal:  AJNR Am J Neuroradiol       Date:  2019-09-19       Impact factor: 3.825

2.  Immediate post-operative aneurysm occlusion after endovascular treatment of intracranial aneurysms with coiling or balloon-assisted coiling in a prospective multicenter cohort of 1189 patients: Analysis of Recanalization after Endovascular Treatment of intracranial Aneurysm (ARETA) Study.

Authors:  Laurent Pierot; Coralie Barbe; Denis Herbreteau; Jean-Yves Gauvrit; Anne-Christine Januel; Fouzi Bala; Frédéric Ricolfi; Hubert Desal; Stéphane Velasco; Mohamed Aggour; Emmanuel Chabert; Jacques Sedat; Denis Trystram; Gaultier Marnat; Sophie Gallas; Georges Rodesch; Frédéric Clarençon; Chrysanthi Papagiannaki; Phil White; Laurent Spelle
Journal:  J Neurointerv Surg       Date:  2020-12-21       Impact factor: 5.836

3.  Shape Modification is Common in Woven EndoBridge-Treated Intracranial Aneurysms: A Longitudinal Quantitative Analysis Study.

Authors:  J Rosskopf; M Braun; J Dreyhaupt; M Beer; B L Schmitz; Y Ozpeynirci
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

4.  Retreatments must be included in the evaluation of device performance.

Authors:  René Chapot; Pascal J Mosimann; Tim E Darsaut; Jean Raymond
Journal:  J Neurointerv Surg       Date:  2020-09-14       Impact factor: 5.836

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.